APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ambulatory Phlebectomy

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ambulatory Phlebectomy Market Analysis and Forecast 2026-2032

11 April 2026212 pages

Choose your research edition.

Industry ResearchAmbulatory Phlebectomy Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Ambulatory Phlebectomy Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Ambulatory Phlebectomy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ambulatory Phlebectomy Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Ambulatory Phlebectomy Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Ambulatory Phlebectomy market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Ambulatory Phlebectomy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ambulatory Phlebectomy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ambulatory Phlebectomy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ambulatory Phlebectomy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Ambulatory Phlebectomy include Medtronic, Boston Scientific, BD, AngioDynamics, Teleflex, Biolitec AG, B. Braun, Merit Medical and Dornier MedTech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Ambulatory Phlebectomy, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ambulatory Phlebectomy, also provides the revenue of main regions and countries. Of the upcoming market potential for Ambulatory Phlebectomy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ambulatory Phlebectomy revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ambulatory Phlebectomy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Ambulatory Phlebectomy revenue, projected growth trends, production technology, application and end-user industry.

Ambulatory Phlebectomy Segment by Company

Medtronic

Boston Scientific

BD

AngioDynamics

Teleflex

Biolitec AG

B. Braun

Merit Medical

Dornier MedTech

Alma Lasers

Ambulatory Phlebectomy Segment by Type

Traditional Ambulatory Phlebectomy

Transilluminated Powered Phlebectomy (TIPP)

Combined Procedure

Ambulatory Phlebectomy Segment by Application

Hospital

Specialized Vein Clinics

Aesthetic Clinics

Ambulatory Phlebectomy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ambulatory Phlebectomy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ambulatory Phlebectomy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ambulatory Phlebectomy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Ambulatory Phlebectomy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Ambulatory Phlebectomy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ambulatory Phlebectomy revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ambulatory Phlebectomy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Traditional Ambulatory Phlebectomy Major Player Table 3. Transilluminated Powered Phlebectomy (TIPP) Major Player Table 4. Combined Procedure Major Player Table 5. Global Ambulatory Phlebectomy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Player Table 7. Specialized Vein Clinics Major Player Table 8. Aesthetic Clinics Major Player Table 9. Ambulatory Phlebectomy Industry Trends Table 10. Ambulatory Phlebectomy Industry Drivers Table 11. Ambulatory Phlebectomy Industry Opportunities and Challenges Table 12. Ambulatory Phlebectomy Industry Restraints Table 13. Global Ambulatory Phlebectomy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Ambulatory Phlebectomy Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Ambulatory Phlebectomy Market Share by Region (2021-2026) Table 16. Global Ambulatory Phlebectomy Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Ambulatory Phlebectomy Market Share by Region (2027-2032) Table 18. Global Ambulatory Phlebectomy Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Ambulatory Phlebectomy Revenue Market Share by Players (2021-2026) Table 20. Global Ambulatory Phlebectomy Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Ambulatory Phlebectomy Key Players Headquarters & Area Served Table 22. Global Ambulatory Phlebectomy Players, Product Type & Application Table 23. Global Ambulatory Phlebectomy Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Ambulatory Phlebectomy by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Ambulatory Phlebectomy Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Ambulatory Phlebectomy Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Ambulatory Phlebectomy Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Ambulatory Phlebectomy Revenue Market Share by Type (2021-2026) Table 30. Global Ambulatory Phlebectomy Revenue Market Share by Type (2027-2032) Table 31. Global Ambulatory Phlebectomy Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Ambulatory Phlebectomy Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Ambulatory Phlebectomy Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Ambulatory Phlebectomy Revenue Market Share by Application (2021-2026) Table 35. Global Ambulatory Phlebectomy Revenue Market Share by Application (2027-2032) Table 36. Medtronic Company Information Table 37. Medtronic Business Overview Table 38. Medtronic Ambulatory Phlebectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Medtronic Ambulatory Phlebectomy Product Portfolio Table 40. Medtronic Recent Development Table 41. Boston Scientific Company Information Table 42. Boston Scientific Business Overview Table 43. Boston Scientific Ambulatory Phlebectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Boston Scientific Ambulatory Phlebectomy Product Portfolio Table 45. Boston Scientific Recent Development Table 46. BD Company Information Table 47. BD Business Overview Table 48. BD Ambulatory Phlebectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. BD Ambulatory Phlebectomy Product Portfolio Table 50. BD Recent Development Table 51. AngioDynamics Company Information Table 52. AngioDynamics Business Overview Table 53. AngioDynamics Ambulatory Phlebectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. AngioDynamics Ambulatory Phlebectomy Product Portfolio Table 55. AngioDynamics Recent Development Table 56. Teleflex Company Information Table 57. Teleflex Business Overview Table 58. Teleflex Ambulatory Phlebectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Teleflex Ambulatory Phlebectomy Product Portfolio Table 60. Teleflex Recent Development Table 61. Biolitec AG Company Information Table 62. Biolitec AG Business Overview Table 63. Biolitec AG Ambulatory Phlebectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Biolitec AG Ambulatory Phlebectomy Product Portfolio Table 65. Biolitec AG Recent Development Table 66. B. Braun Company Information Table 67. B. Braun Business Overview Table 68. B. Braun Ambulatory Phlebectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. B. Braun Ambulatory Phlebectomy Product Portfolio Table 70. B. Braun Recent Development Table 71. Merit Medical Company Information Table 72. Merit Medical Business Overview Table 73. Merit Medical Ambulatory Phlebectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Merit Medical Ambulatory Phlebectomy Product Portfolio Table 75. Merit Medical Recent Development Table 76. Dornier MedTech Company Information Table 77. Dornier MedTech Business Overview Table 78. Dornier MedTech Ambulatory Phlebectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Dornier MedTech Ambulatory Phlebectomy Product Portfolio Table 80. Dornier MedTech Recent Development Table 81. Alma Lasers Company Information Table 82. Alma Lasers Business Overview Table 83. Alma Lasers Ambulatory Phlebectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Alma Lasers Ambulatory Phlebectomy Product Portfolio Table 85. Alma Lasers Recent Development Table 86. North America Ambulatory Phlebectomy Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Ambulatory Phlebectomy Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Ambulatory Phlebectomy Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Ambulatory Phlebectomy Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Ambulatory Phlebectomy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Ambulatory Phlebectomy Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Ambulatory Phlebectomy Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Ambulatory Phlebectomy Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Ambulatory Phlebectomy Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Ambulatory Phlebectomy Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Ambulatory Phlebectomy Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Ambulatory Phlebectomy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Ambulatory Phlebectomy Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Ambulatory Phlebectomy Revenue by Country (US$ Million) & (2027-2032) Table 100. China Ambulatory Phlebectomy Revenue by Type (2021-2026) & (US$ Million) Table 101. China Ambulatory Phlebectomy Revenue by Type (2027-2032) & (US$ Million) Table 102. China Ambulatory Phlebectomy Revenue by Application (2021-2026) & (US$ Million) Table 103. China Ambulatory Phlebectomy Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Ambulatory Phlebectomy Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Ambulatory Phlebectomy Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Ambulatory Phlebectomy Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Ambulatory Phlebectomy Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Ambulatory Phlebectomy Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Ambulatory Phlebectomy Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Ambulatory Phlebectomy Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Ambulatory Phlebectomy Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Ambulatory Phlebectomy Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Ambulatory Phlebectomy Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Ambulatory Phlebectomy Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Ambulatory Phlebectomy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Ambulatory Phlebectomy Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Ambulatory Phlebectomy Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Ambulatory Phlebectomy Image Figure 2. Global Ambulatory Phlebectomy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ambulatory Phlebectomy Market Size Share 2021 VS 2025 VS 2032 Figure 4. Traditional Ambulatory Phlebectomy Image Figure 5. Transilluminated Powered Phlebectomy (TIPP) Image Figure 6. Combined Procedure Image Figure 7. Global Ambulatory Phlebectomy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Ambulatory Phlebectomy Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Specialized Vein Clinics Image Figure 11. Aesthetic Clinics Image Figure 12. Global Ambulatory Phlebectomy Market Size (US$ Million) & (2021-2032) Figure 13. Global Ambulatory Phlebectomy Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Ambulatory Phlebectomy Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Ambulatory Phlebectomy Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Ambulatory Phlebectomy Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Ambulatory Phlebectomy Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Ambulatory Phlebectomy Revenue Market Share by Type (2021-2032) Figure 20. Global Ambulatory Phlebectomy Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Ambulatory Phlebectomy Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Ambulatory Phlebectomy Revenue Market Share by Application (2021-2032) Figure 23. North America Ambulatory Phlebectomy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Ambulatory Phlebectomy Revenue Share by Type (2021-2032) Figure 25. North America Ambulatory Phlebectomy Revenue Share by Application (2021-2032) Figure 26. North America Ambulatory Phlebectomy Revenue Share by Country (2021-2032) Figure 27. United States Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Ambulatory Phlebectomy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Ambulatory Phlebectomy Revenue Share by Type (2021-2032) Figure 32. Europe Ambulatory Phlebectomy Revenue Share by Application (2021-2032) Figure 33. Europe Ambulatory Phlebectomy Revenue Share by Country (2021-2032) Figure 34. Germany Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Ambulatory Phlebectomy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Ambulatory Phlebectomy Revenue Share by Type (2021-2032) Figure 44. China Ambulatory Phlebectomy Revenue Share by Application (2021-2032) Figure 45. Asia Ambulatory Phlebectomy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Ambulatory Phlebectomy Revenue Share by Type (2021-2032) Figure 47. Asia Ambulatory Phlebectomy Revenue Share by Application (2021-2032) Figure 48. Asia Ambulatory Phlebectomy Revenue Share by Region (2021-2032) Figure 49. Japan Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Ambulatory Phlebectomy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Ambulatory Phlebectomy Revenue Share by Type (2021-2032) Figure 57. SAMEA Ambulatory Phlebectomy Revenue Share by Application (2021-2032) Figure 58. SAMEA Ambulatory Phlebectomy Revenue Share by Country (2021-2032) Figure 59. Brazil Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Ambulatory Phlebectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Traditional Ambulatory Phlebectomy
  • Transilluminated Powered Phlebectomy (TIPP)
  • Combined Procedure
Applications
  • Hospital
  • Specialized Vein Clinics
  • Aesthetic Clinics
Companies covered
  • Medtronic
  • Boston Scientific
  • BD
  • AngioDynamics
  • Teleflex
  • Biolitec AG
  • B. Braun
  • Merit Medical
  • Dornier MedTech
  • Alma Lasers

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ambulatory Phlebectomy Market by Type
  3. 1.2.1 Global Ambulatory Phlebectomy Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Traditional Ambulatory Phlebectomy
  5. 1.2.3 Transilluminated Powered Phlebectomy (TIPP)
  6. 1.2.4 Combined Procedure
  7. 1.3 Ambulatory Phlebectomy Market by Application
  8. 1.3.1 Global Ambulatory Phlebectomy Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Specialized Vein Clinics
  11. 1.3.4 Aesthetic Clinics
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Ambulatory Phlebectomy Market Dynamics
  1. 2.1 Ambulatory Phlebectomy Industry Trends
  2. 2.2 Ambulatory Phlebectomy Industry Drivers
  3. 2.3 Ambulatory Phlebectomy Industry Opportunities and Challenges
  4. 2.4 Ambulatory Phlebectomy Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Ambulatory Phlebectomy Market Perspective (2021-2032)
  2. 3.2 Global Ambulatory Phlebectomy Growth Trends by Region
  3. 3.2.1 Global Ambulatory Phlebectomy Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ambulatory Phlebectomy Market Size by Region (2021-2026)
  5. 3.2.3 Global Ambulatory Phlebectomy Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Ambulatory Phlebectomy Revenue by Players
  2. 4.1.1 Global Ambulatory Phlebectomy Revenue by Players (2021-2026)
  3. 4.1.2 Global Ambulatory Phlebectomy Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Ambulatory Phlebectomy Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ambulatory Phlebectomy Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Ambulatory Phlebectomy Key Players Headquarters & Area Served
  7. 4.4 Global Ambulatory Phlebectomy Players, Product Type & Application
  8. 4.5 Global Ambulatory Phlebectomy Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Ambulatory Phlebectomy Market CR5 and HHI
  11. 4.6.3 2025 Ambulatory Phlebectomy Tier 1, Tier 2, and Tier 3
5 Ambulatory Phlebectomy Market Size by Type
  1. 5.1 Global Ambulatory Phlebectomy Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Ambulatory Phlebectomy Revenue by Type (2021-2032)
  3. 5.3 Global Ambulatory Phlebectomy Revenue Market Share by Type (2021-2032)
6 Ambulatory Phlebectomy Market Size by Application
  1. 6.1 Global Ambulatory Phlebectomy Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Ambulatory Phlebectomy Revenue by Application (2021-2032)
  3. 6.3 Global Ambulatory Phlebectomy Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Medtronic
  2. 7.1.1 Medtronic Company Information
  3. 7.1.2 Medtronic Business Overview
  4. 7.1.3 Medtronic Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Medtronic Ambulatory Phlebectomy Product Portfolio
  6. 7.1.5 Medtronic Recent Developments
  7. 7.2 Boston Scientific
  8. 7.2.1 Boston Scientific Company Information
  9. 7.2.2 Boston Scientific Business Overview
  10. 7.2.3 Boston Scientific Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Boston Scientific Ambulatory Phlebectomy Product Portfolio
  12. 7.2.5 Boston Scientific Recent Developments
  13. 7.3 BD
  14. 7.3.1 BD Company Information
  15. 7.3.2 BD Business Overview
  16. 7.3.3 BD Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BD Ambulatory Phlebectomy Product Portfolio
  18. 7.3.5 BD Recent Developments
  19. 7.4 AngioDynamics
  20. 7.4.1 AngioDynamics Company Information
  21. 7.4.2 AngioDynamics Business Overview
  22. 7.4.3 AngioDynamics Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  23. 7.4.4 AngioDynamics Ambulatory Phlebectomy Product Portfolio
  24. 7.4.5 AngioDynamics Recent Developments
  25. 7.5 Teleflex
  26. 7.5.1 Teleflex Company Information
  27. 7.5.2 Teleflex Business Overview
  28. 7.5.3 Teleflex Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Teleflex Ambulatory Phlebectomy Product Portfolio
  30. 7.5.5 Teleflex Recent Developments
  31. 7.6 Biolitec AG
  32. 7.6.1 Biolitec AG Company Information
  33. 7.6.2 Biolitec AG Business Overview
  34. 7.6.3 Biolitec AG Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Biolitec AG Ambulatory Phlebectomy Product Portfolio
  36. 7.6.5 Biolitec AG Recent Developments
  37. 7.7 B. Braun
  38. 7.7.1 B. Braun Company Information
  39. 7.7.2 B. Braun Business Overview
  40. 7.7.3 B. Braun Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  41. 7.7.4 B. Braun Ambulatory Phlebectomy Product Portfolio
  42. 7.7.5 B. Braun Recent Developments
  43. 7.8 Merit Medical
  44. 7.8.1 Merit Medical Company Information
  45. 7.8.2 Merit Medical Business Overview
  46. 7.8.3 Merit Medical Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Merit Medical Ambulatory Phlebectomy Product Portfolio
  48. 7.8.5 Merit Medical Recent Developments
  49. 7.9 Dornier MedTech
  50. 7.9.1 Dornier MedTech Company Information
  51. 7.9.2 Dornier MedTech Business Overview
  52. 7.9.3 Dornier MedTech Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Dornier MedTech Ambulatory Phlebectomy Product Portfolio
  54. 7.9.5 Dornier MedTech Recent Developments
  55. 7.10 Alma Lasers
  56. 7.10.1 Alma Lasers Company Information
  57. 7.10.2 Alma Lasers Business Overview
  58. 7.10.3 Alma Lasers Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Alma Lasers Ambulatory Phlebectomy Product Portfolio
  60. 7.10.5 Alma Lasers Recent Developments
8 North America
  1. 8.1 North America Ambulatory Phlebectomy Revenue (2021-2032)
  2. 8.2 North America Ambulatory Phlebectomy Revenue by Type (2021-2032)
  3. 8.2.1 North America Ambulatory Phlebectomy Revenue by Type (2021-2026)
  4. 8.2.2 North America Ambulatory Phlebectomy Revenue by Type (2027-2032)
  5. 8.3 North America Ambulatory Phlebectomy Revenue Share by Type (2021-2032)
  6. 8.4 North America Ambulatory Phlebectomy Revenue by Application (2021-2032)
  7. 8.4.1 North America Ambulatory Phlebectomy Revenue by Application (2021-2026)
  8. 8.4.2 North America Ambulatory Phlebectomy Revenue by Application (2027-2032)
  9. 8.5 North America Ambulatory Phlebectomy Revenue Share by Application (2021-2032)
  10. 8.6 North America Ambulatory Phlebectomy Revenue by Country
  11. 8.6.1 North America Ambulatory Phlebectomy Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Ambulatory Phlebectomy Revenue by Country (2021-2026)
  13. 8.6.3 North America Ambulatory Phlebectomy Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Ambulatory Phlebectomy Revenue (2021-2032)
  2. 9.2 Europe Ambulatory Phlebectomy Revenue by Type (2021-2032)
  3. 9.2.1 Europe Ambulatory Phlebectomy Revenue by Type (2021-2026)
  4. 9.2.2 Europe Ambulatory Phlebectomy Revenue by Type (2027-2032)
  5. 9.3 Europe Ambulatory Phlebectomy Revenue Share by Type (2021-2032)
  6. 9.4 Europe Ambulatory Phlebectomy Revenue by Application (2021-2032)
  7. 9.4.1 Europe Ambulatory Phlebectomy Revenue by Application (2021-2026)
  8. 9.4.2 Europe Ambulatory Phlebectomy Revenue by Application (2027-2032)
  9. 9.5 Europe Ambulatory Phlebectomy Revenue Share by Application (2021-2032)
  10. 9.6 Europe Ambulatory Phlebectomy Revenue by Country
  11. 9.6.1 Europe Ambulatory Phlebectomy Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Ambulatory Phlebectomy Revenue by Country (2021-2026)
  13. 9.6.3 Europe Ambulatory Phlebectomy Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Ambulatory Phlebectomy Revenue (2021-2032)
  2. 10.2 China Ambulatory Phlebectomy Revenue by Type (2021-2032)
  3. 10.2.1 China Ambulatory Phlebectomy Revenue by Type (2021-2026)
  4. 10.2.2 China Ambulatory Phlebectomy Revenue by Type (2027-2032)
  5. 10.3 China Ambulatory Phlebectomy Revenue Share by Type (2021-2032)
  6. 10.4 China Ambulatory Phlebectomy Revenue by Application (2021-2032)
  7. 10.4.1 China Ambulatory Phlebectomy Revenue by Application (2021-2026)
  8. 10.4.2 China Ambulatory Phlebectomy Revenue by Application (2027-2032)
  9. 10.5 China Ambulatory Phlebectomy Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ambulatory Phlebectomy Revenue (2021-2032)
  2. 11.2 Asia Ambulatory Phlebectomy Revenue by Type (2021-2032)
  3. 11.2.1 Asia Ambulatory Phlebectomy Revenue by Type (2021-2026)
  4. 11.2.2 Asia Ambulatory Phlebectomy Revenue by Type (2027-2032)
  5. 11.3 Asia Ambulatory Phlebectomy Revenue Share by Type (2021-2032)
  6. 11.4 Asia Ambulatory Phlebectomy Revenue by Application (2021-2032)
  7. 11.4.1 Asia Ambulatory Phlebectomy Revenue by Application (2021-2026)
  8. 11.4.2 Asia Ambulatory Phlebectomy Revenue by Application (2027-2032)
  9. 11.5 Asia Ambulatory Phlebectomy Revenue Share by Application (2021-2032)
  10. 11.6 Asia Ambulatory Phlebectomy Revenue by Country
  11. 11.6.1 Asia Ambulatory Phlebectomy Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Ambulatory Phlebectomy Revenue by Country (2021-2026)
  13. 11.6.3 Asia Ambulatory Phlebectomy Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ambulatory Phlebectomy Revenue (2021-2032)
  2. 12.2 SAMEA Ambulatory Phlebectomy Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Ambulatory Phlebectomy Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Ambulatory Phlebectomy Revenue by Type (2027-2032)
  5. 12.3 SAMEA Ambulatory Phlebectomy Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Ambulatory Phlebectomy Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Ambulatory Phlebectomy Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Ambulatory Phlebectomy Revenue by Application (2027-2032)
  9. 12.5 SAMEA Ambulatory Phlebectomy Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Ambulatory Phlebectomy Revenue by Country
  11. 12.6.1 SAMEA Ambulatory Phlebectomy Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Ambulatory Phlebectomy Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Ambulatory Phlebectomy Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst